Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Freeline Therapeutics Holdings Plc Adss
(NQ:
FRLN
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Feb 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Freeline Therapeutics Holdings Plc Adss
< Previous
1
2
3
4
Next >
Freeline Therapeutics Announces Second Round Of Layoffs, Shelves Fabry Disease Program
April 04, 2023
Via
Benzinga
Earnings Scheduled For April 4, 2023
April 04, 2023
Companies Reporting Before The Bell • Freeline Therapeutics (NASDAQ:FRLN) is projected to report earnings for its fourth quarter.
Via
Benzinga
Earnings Preview For Freeline Therapeutics
April 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 20, 2023
Via
Benzinga
Freeline Therapeutics Stops Further Development On Hemophilia Program, Cuts Workforce
November 15, 2022
Via
Benzinga
HC Wainwright Cuts Price For This Small Cap 'Reflecting Potential Pause In Hemophilia Program'
August 22, 2022
Via
Benzinga
Recap: Freeline Therapeutics Q2 Earnings
August 09, 2022
Freeline Therapeutics (NASDAQ:FRLN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
Protalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group,
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
Freeline Posts Cases Of Lower FIX Expression, Higher Liver Enzymes From Hemophilia Candidate
July 11, 2022
Via
Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a...
Via
Benzinga
This Penny Stock Touts Encouraging Long-Term Data For Hemophilia Gene Therapy
July 21, 2022
Small biotech Freeline Therapeutics Holdings plc (NASDAQ: FRLN) hopes new long-term data will help boost its case.
Via
Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
July 11, 2022
U.S. stocks traded lower toward the end of trading as investors digested the recent jobs report for the month of June.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 11, 2022
Via
Benzinga
Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher
July 11, 2022
U.S. stocks traded lower midway through trading following the release of jobs report on Friday.
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
June 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 06, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 28, 2022
Welcome back, trader! It's time to start off the week with an overview of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
22 Stocks Moving in Monday's Pre-Market Session
March 28, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 27.3% to $1.63 in pre-market trading. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding.
Via
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...
Via
Benzinga
52 Weeks High And Low Article
January 11, 2022
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.